These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2792662)

  • 1. Blockade of the hydroosmotic effect of vasopressin normalizes water excretion in cirrhotic rats.
    Claria J; Jiménez W; Arroyo V; Guarner F; López C; La Villa G; Asbert M; Rivera F; Rodés J
    Gastroenterology; 1989 Nov; 97(5):1294-9. PubMed ID: 2792662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal relationship between the impairment of free water excretion and antidiuretic hormone hypersecretion in rats with experimental cirrhosis.
    Camps J; Solá J; Arroyo V; Pérez-Ayuso RM; Gaya J; Rivera F; Rodés J
    Gastroenterology; 1987 Sep; 93(3):498-505. PubMed ID: 3609659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of solute-free water retention in experimental ascitic cirrhosis: is vasopressin the only culprit?
    Sansoè G; Aragno M; Mastrocola R; Parola M
    Clin Sci (Lond); 2016 Jan; 130(2):117-24. PubMed ID: 26519424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal water handling in rats with decompensated liver cirrhosis.
    Jonassen TE; Christensen S; Kwon TH; Langhoff S; Salling N; Nielsen S
    Am J Physiol Renal Physiol; 2000 Dec; 279(6):F1101-9. PubMed ID: 11097629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic efficacy of the non-peptide AVP antagonist OPC-31260 in cirrhotic rats.
    Tsuboi Y; Ishikawa S; Fujisawa G; Okada K; Saito T
    Kidney Int; 1994 Jul; 46(1):237-44. PubMed ID: 7933842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aquaretic effect of the kappa-opioid agonist RU 51599 in cirrhotic rats with ascites and water retention.
    Bosch-Marcé M; Jiménez W; Angeli P; Leivas A; Clària J; Graziotto A; Arroyo V; Rivera F; Rodés J
    Gastroenterology; 1995 Jul; 109(1):217-23. PubMed ID: 7797019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of V1-vasopressin receptor blockade on arterial pressure in conscious rats with cirrhosis and ascites.
    Claria J; Jiménez W; Arroyo V; La Villa G; López C; Asbert M; Castro A; Gaya J; Rivera F; Rodés J
    Gastroenterology; 1991 Feb; 100(2):494-501. PubMed ID: 1824629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term aquaretic efficacy of a selective nonpeptide V(2)-vasopressin receptor antagonist, SR121463, in cirrhotic rats.
    Jiménez W; Gal CS; Ros J; Cano C; Cejudo P; Morales-Ruiz M; Arroyo V; Pascal M; Rivera F; Maffrand JP; Rodés J
    J Pharmacol Exp Ther; 2000 Oct; 295(1):83-90. PubMed ID: 10991964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased vasopressin-mediated renal water reabsorption in rats with compensated liver cirrhosis.
    Jonassen TE; Nielsen S; Christensen S; Petersen JS
    Am J Physiol; 1998 Aug; 275(2):F216-25. PubMed ID: 9691010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites.
    Martin PY; Ohara M; Gines P; Xu DL; St John J; Niederberger M; Schrier RW
    J Clin Invest; 1998 Jan; 101(1):235-42. PubMed ID: 9421486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery and therapeutic utility of vasopressin antagonists in rats.
    Kinter LB; Dytko G; Ashton D; McDonald J; Huffman W; Stassen F
    J Cardiovasc Pharmacol; 1986; 8 Suppl 7():S36-43. PubMed ID: 2434770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin gene expression in rats with experimental cirrhosis.
    Kim JK; Summer SN; Howard RL; Schrier RW
    Hepatology; 1993 Jan; 17(1):143-7. PubMed ID: 8423035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic and diagnostic potential of a vasopressin-2 antagonist for impaired water handling in cirrhosis.
    Inoue T; Ohnishi A; Matsuo A; Kawai B; Kunihiro N; Tada Y; Koizumi F; Chau T; Okada K; Yamamura Y; Tanaka T
    Clin Pharmacol Ther; 1998 May; 63(5):561-70. PubMed ID: 9630829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of vasopressin in abnormal water excretion in cirrhotic patients.
    Bichet D; Szatalowicz V; Chaimovitz C; Schrier RW
    Ann Intern Med; 1982 Apr; 96(4):413-7. PubMed ID: 7065556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of vasopressin antagonist d(CH2)5Tyr(Et)VAVP on plasma arginine vasopressin level after osmotic stimulus.
    László FA; Laczi F; Janáky T; Baláspiri L
    Endocr Regul; 1991 Sep; 25(3):181-3. PubMed ID: 1764609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of hyponatraemia and cerebral oedema by the vasopressin antagonist d/CH2/5Tyr/Et/VAVP in rats treated with pitressin tannate.
    László FA; Csáti S; Baláspiri L
    Acta Endocrinol (Copenh); 1984 May; 106(1):56-60. PubMed ID: 6730855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired free water excretion in child C cirrhosis and ascites: relations to distal tubular function and the vasopressin system.
    Krag A; Møller S; Pedersen EB; Henriksen JH; Holstein-Rathlou NH; Bendtsen F
    Liver Int; 2010 Oct; 30(9):1364-70. PubMed ID: 20731774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained aquaretic effect of the V2-AVP receptor antagonist, RWJ-351647, in cirrhotic rats with ascites and water retention.
    Ros J; Fernández-Varo G; Muñoz-Luque J; Arroyo V; Rodés J; Gunnet JW; Demarest KT; Jiménez W
    Br J Pharmacol; 2005 Nov; 146(5):654-61. PubMed ID: 16113688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the vasopressin antagonist d/CH2/5Tyr/Et/VAVP on the antidiuretic action of exogenous and endogenous vasopressin.
    László FA; Csáti S; Baláspiri L
    Acta Endocrinol (Copenh); 1984 May; 106(1):52-5. PubMed ID: 6730854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Renal effects of the chronic inhibition of nitric oxide synthesis in cirrhotic rats with ascites].
    Ortiz MC; Fortepiani LA; Martínez-Salgado C; Eleno N; Atucha NM; López-Novoa JM; García-Estañ J
    Nefrologia; 2001; 21(6):556-64. PubMed ID: 11881425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.